Cover Image
市場調查報告書

全球抗真菌藥物市場考察,機會分析,市場佔有率,預測

Global Antifungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 361168
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球抗真菌藥物市場考察,機會分析,市場佔有率,預測 Global Antifungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年06月18日 內容資訊: 英文 140 Pages
簡介

全球抗真菌藥物市場,2022年預計達到102億美元。市場預計2016年∼2022年強勁成長。

本報告提供全球抗真菌藥物市場相關調查分析,市場概要,市場決策要素,市場區隔,各地區的市場分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場考察
  • 競爭情形
  • 五力分析模型
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 藥物的各類型
  • 各治療指標
  • 各應用

第5章 各地區的市場分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • ABBOTT LABORATORIES.
  • ALTERNARIA
  • ASPERQILLUS
  • ASTELLAS PHARMA INC.
  • BAYER HEALTHCARE
  • ENZON PHARMACEUTICALS
  • GILEAD
  • GLAXOSMITHKLINE
  • JOHNSON & JOHNSON
  • KRAMER LABORATORIES
  • MERCK & CO.
  • NOVARTIS
  • PFIZER
  • SANOFI-AVENTIS
  • VERTEX PHARMACEUTICALS

圖表

目錄
Product Code: HME-280714

The global antifungal agents market was estimated to grow around $10,200 million and it is expected to experience robust growth during 2016-2022.Antifungal agent is basically a drug which helps in detecting and eliminating fungal pathogens from foreign body with less toxic side effects to the body.These agents are also helpful in wide range of applications such as ointments, drugs and others.

The antifungal agents market is forecasted to grow at higher rate in future due to rapid growth and rising concern of people regarding health in all over the world. Rising fungal infections is another factor fuelling the global antifungal agents market. Rising popularity of over-the-counter drugs segment in all over the world is another major factor driving the global antifungal agents market.Although there are many factors which drive this market, but still there are various challenges which yet to be faced by the market such as limitations associated with drugs used for treatments, new technological advancements etc. There are some restraints present in the globalantifungal agents market such as high penetration of conventional drugs, stringent rules and regulations for market players etc. and it is going to be key factor hampering the growth of the market.

The global antifungal agents market is segmented on the basis of drugs type, therapeutic indication, applications and by geography. On the basis of drugs type, the market is segmented into echinocandins, azoles, ployenes, allylamines, others etc. Among all drugs types, azoles antifungal dominates the global antifungal market which also helps in fuelling the growth of this market. On the basis of applications, the market is segmented into powders, ointments, drugs, and pastes etc. Among all applications, drugs hold largest market share and it is expected to witness significant growth during the forecasted period of time. On the basis of therapeutic indications, the market is segmented into aspergillosis, dermatophytosis, candidiasis, others etc. Among all therapeutic indications, aspergillosis and candidiasis is expected to witness promising growth in near future.On the basis of geography, Europe, Asia Pacific North America, and ROW are the major segments of this global antifungal agents market. North America is the leading market in antifungal agents due to promising growth of healthcare industry in all over the world.However, Asia would be the fastest growing region for global antifungal agents market. The major reason is rising healthcare infrastructure as well as rising fungal infections across the globe.

Some of the major players of the market includes Abbott Laboratories., Alternaria, Asperqillus, Astellas Pharma Inc., and Bayer Healthcare, Enzon Pharmaceuticals, Gilead, Glaxosmithkline, Johnson & Johnson, Kramer Laboratories, Merck & Co. and so on. Mergers, product launches, innovation and expansion are some of the key strategies adopted by the market players. On 27th March 2015, Johnson & Johnson has announced its collaboration with Google for the purpose of advance surgical robots. This collaboration was expected to help in benefiting patients, surgeons and healthcare systems.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP 3 GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING NUMBER OF PATIENTS SUFFERING FROM HYGIENE RELATED DISEASES
    • 3.1.2. RISING AWARENESS AMONG KEY PLAYERS REGARDING MYRIAD FUNGAL INFECTIONS
    • 3.1.3. RISING GOVERNMENT INITIATIVES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH PENETRATION OF CONVENTIONAL DRUGS
    • 3.2.2. STRINGENT GOVERNMENT REGULATIONS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING HEALTHCARE INDUSTRY
    • 3.3.2. GROWING POPULARITY OF OVER-THE-COUNTER DRUG SEGMENT
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LIMITATIONS ASSOCIATED WITH DRUGS USED FOR TREATMENTS
    • 3.4.2. NEW TECHNOLOGICAL ADVANCEMENTS
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL ANTI FUNGAL AGENTS MARKET BY DRUG TYPES MARKET 2014-2022 ($ MILLION)
    • 4.1.1. GLOBAL ECHINOCANDINS MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL AZOLES MARKET 2014-2022 ( $ MILLION)
    • 4.1.3. GLOBAL PLOYENES MARKET 2014-2022 ($ MILLION)
    • 4.1.4. GLOBAL ALLYLAMINES MARKET 2014-2022 ($ MILLION)
    • 4.1.5. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 4.2. GLOBAL ANTI FUNGAL AGENTS MARKET BY THERAPEUTIC INDICATIONS MARKET 2014-2022 ($ MILLION)
    • 4.2.1. GLOBAL ASPERGILLOSIS MARKET 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL DERMATOPHYTOSIS MARKET 2014-2022 ($ MILLION)
    • 4.2.3. GLOBAL CANDIDIASIS MARKET 2014-2022 ($ MILLION)
    • 4.2.4. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 4.3. GLOBAL ANTI FUNGAL AGENTS MARKET BY APPLICATIONS MARKET 2014-2022 ($ MILLION)
    • 4.3.1. GLOBAL POWDERS MARKET 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL OINTMENTS MARKET 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.3.4. GLOBAL PASTES MARKET 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.4. ROAPAC ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILING: - (OVER SCOT ANALYSIS STRATEGIC REVIEW)

  • 1. ABBOTT LABORATORIES.
  • 2. ALTERNARIA
  • 3. ASPERQILLUS
  • 4. ASTELLAS PHARMA INC.
  • 5. BAYER HEALTHCARE
  • 6. ENZON PHARMACEUTICALS
  • 7. GILEAD
  • 8. GLAXOSMITHKLINE
  • 9. JOHNSON & JOHNSON
  • 10. KRAMER LABORATORIES
  • 11. MERCK & CO.
  • 12. NOVARTIS
  • 13. PFIZER
  • 14. SANOFI-AVENTIS
  • 15. VERTEX PHARMACEUTICALS

LIST OF TABLES

  • 1. GLOBAL ANTIFUNGAL AGENTS MARKET BY DRUG TYPES MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL ECHINOCANDINS MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL AZOLES MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL PLOYENES MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL ALLYLAMINES MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL ANTIFUNGAL AGENTS MARKET BY THERAPEUTIC INDICATIONS MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL ASPERGILLOSIS MARKET 2014-2022 ($ MILLION)
  • 9. GLOBAL DERMATOPHYTOSIS MARKET 2014-2022 ($ MILLION)
  • 10. GLOBAL CANDIDIASIS MARKET 2014-2022 ($ MILLION)
  • 11. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 12. GLOBAL ANTIFUNGAL AGENTS MARKET BY APPLICATIONS MARKET 2014-2022 ($ MILLION)
  • 13. GLOBAL POWDERS MARKET 2014-2022 ($ MILLION)
  • 14. GLOBAL OINTMENTS MARKET 2014-2022 ($ MILLION)
  • 15. GLOBAL DRUGS MARKET 2014-2022 ($ MILLION)
  • 16. GLOBAL PASTES MARKET2014-2022 ($ MILLION)
  • 17. NORTH AMERICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 18. EUROPE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 19. ASIA PACIFIC ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 20. REST OF THE WORLD ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANTIFUNGAL AGENTS MARKET BY DRUG TYPES MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL ECHINOCANDINS MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL AZOLES MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL PLOYENES MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL ALLYLAMINES MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL ANTIFUNGAL AGENTS MARKET BY THERAPEUTIC INDICATIONS MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL ASPERGILLOSIS MARKET 2014-2022 ($ MILLION)
  • 9. GLOBAL DERMATOPHYTOSIS MARKET 2014-2022 ($ MILLION)
  • 10. GLOBAL CANDIDIASIS MARKET 2014-2022 ($ MILLION)
  • 11. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 12. GLOBAL ANTI FUNGAL AGENTS MARKET BY APPLICATIONS MARKET 2014-2022 ($ MILLION)
  • 13. GLOBAL POWDERS MARKET 2014-2022 ($ MILLION)
  • 14. GLOBAL OINTMENTS MARKET 2014-2022 ($ MILLION)
  • 15. GLOBAL DRUGS MARKET 2014-2022 ($ MILLION)
  • 16. GLOBAL PASTES MARKET 2014-2022 ($ MILLION)
  • 17. NORTH AMERICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 18. UNITED STATES (U.S.) ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 19. CANADA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 20. EUROPE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 21. UNITED KINGDOM (UK) ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 22. FRANCE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 23. GERMANY ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 24. SPAIN ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 25. ITALY ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 26. ROE ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 27. ASIA PACIFIC ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 28. INDIA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 29. CHINA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 30. JAPAN ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 31. KOREA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 32. AUSTRALIA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 33. ROAPAC ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 34. REST OF THE WORLD ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 35. LATIN AMERICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 36. MENA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
  • 37. AFRICA ANTI FUNGAL AGENTS MARKET 2014-2022 ($ MILLION)
Back to Top